Insider buying
~$50K2,490 sh @ $20.27
Traded Apr 9, 2025 · filed 1 day later
A Palvella Therapeutics director paid $50K out of pocket for Palvella Therapeutics shares. Shares held went up 23% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 9, 2025 · Filed Apr 10, 2025
A Palvella Therapeutics director paid $50K out of pocket for Palvella Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$50,325
Shares × reported transaction price
$25K–$100K
+1.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 4 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
9 days after results of Mar 31, 2025, 36 days before results of May 15, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +17.0% | −3.8% | +20.7% |
| 30 days | −4.6% | +9.2% | −13.8% |
| 90 days | +23.8% | +17.2% | +6.6% |
| 180 days | +244.0% | +26.1% | +217.9% |
| 365 days | +492.8% | +28.5% | +464.3% |
Past results only. Not a forecast.
Insider buying
Traded Apr 9, 2025 · filed 1 day later
A Palvella Therapeutics director paid $50K out of pocket for Palvella Therapeutics shares. Shares held went up 23% with this purchase.
Fund moves
2 tracked managers disclosed the same change for Q4 2024. Among this manager's largest new positions for Q4 2024.
Fund moves
2 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.